Fundz

Kazia Therapeutics Appoints Dr. Sudha Rao as Chief Scientific Officer

PUBLIC · KZIAApr 15, 2026

Position

Chief Scientific Officer

Company

Kazia Therapeutics

Sudha Rao
SydneyBiotechnologyHealth Care

Description

Kazia Therapeutics has announced the appointment of Dr. Sudha Rao as Chief Scientific Officer. Dr

Quick answer

Kazia Therapeutics Appoints Dr. Sudha Rao as Chief Scientific Officer (April 15, 2026). Kazia Therapeutics is based in Sydney, New South Wales, Australia.

Who is the new Chief Scientific Officer at Kazia Therapeutics?
Kazia Therapeutics named Sudha Rao Chief Scientific Officer, announced April 15, 2026.
What did Kazia Therapeutics announce on April 15, 2026?
Kazia Therapeutics has announced the appointment of Dr. Sudha Rao as Chief Scientific Officer.
What does Kazia Therapeutics do?
Kazia Therapeutics is a clinical-stage oncology company developing differentiated therapies for cancers with high unmet need.
Where is Kazia Therapeutics based?
Kazia Therapeutics is based in Sydney, New South Wales, Australia.
Which similar companies made leadership changes around the same time?
Evotec (April 15, 2026), NTT Research (April 15, 2026), Clinical Trial Media (April 15, 2026) and Lenstec (April 15, 2026) also announced leadership changes within 45 days of Kazia Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Biotechnology and Health Care

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Kazia Therapeutics, and when

A new leader at Kazia Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Kazia Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Kazia Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Kazia Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Kazia Therapeutics

Location

Level 24, Three International Towers

Sydney, New South Wales, Australia

About

Kazia Therapeutics is a clinical-stage oncology company developing differentiated therapies for cancers with high unmet need. The company focuses on innovative drug development and is based in Sydney, Australia.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Kazia Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Jeffrey
Likely contact at this company
••••••••@••••••••

See Jeffrey's verified email →

Michael
Senior decision-maker at this company
••••••••@••••••••

See Michael's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Kazia Therapeutics's next move

Learn about Strategic plan

Kazia Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.